Skip to contentN
National Health Investors Inc
N
NHINational Health Investors Inc Q4 2020 · 10-K
Revenue$81.26M$81.26M−1.1% vs Q4 2019 Net Income$37.14M$37.14M−11.7% vs Q4 2019 EPS Diluted$0.83$0.83−12.6% vs Q4 2019 Margins · derivedNet margin45.7%−5.4 pt vs Q4 2019
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Feb 22, 2021 · 53 d after period end